SYNTA66

SYNTA66

Stock Code: 3575602
Manufacturer Part No: SML1949-25MG
Order Now for 7 day delivery
£484.71 (exc VAT) per 25MG
Quantity: - +

Application


Synta66 has been used:as a Ca2+release-activated calcium (CRAC) channel inhibitor to study its effects on ORAI isoformsas an ORAI1 blocker to study its effects on the entry of Ca2+ in chronic lymphocytic leukemia (CLL) B cellsas a CRAC blocker to study its effects on the influx of Ca2+ by store-operated Ca2+entry (SOCE) in enamel cells


Biochem/physiol Actions


Synta66 (S66) is a CRAC (Ca2+ release-activated Ca2+) channel inhibitor that blocks SOCE (store-operated Ca2+ entry) upon Ca2+ depletion from intracellular stores by thapsigargin in human vascular smooth muscle cells (VSMCs) with high potency (IC50 = 26 nM & 43 nM based on maximum Ca2+ level & rate of increase, respectly). Synta66 exhibits no affinity toward a range of receptors and ion channels (e.g. L-type Ca2+ channel) and does not affect TRPC1/5-mediated SOCE or store-operated non-selective cationic current. Leukocytes are reported to be less sensitive to CRAC inhibition by Synta66 (IC50 = 1.76 µM/HL-60, 1 ?M/Jurkat, 1.4 µM/rat RBL).

Colourwhite to beige
Quality Level100
ManufacturerSIGMA-ALDRICH
Storage Temp.2-8°C
SolubilityDMSO: 20 mg/mL, clear
Formpowder
Assay≥98% (HPLC)

There are no downloads for this product.